All information presented is intended solely for educational and scientific discussion purposes regarding peptide research
Private health insurance companies in the United States often take their cues from Medicare and Medicaid when it comes to deciding whether or not to cover a certain treatment
Decades of clinical research have demonstrated their safety and efficacy, and they are now FDA-approved specifically for chronic weight management in adults with obesity or overweight with at least one weight-related health condition
Prescriptions soared to more than 18 million annually
Discontinuation, regain, and reinitiation (class-level, semaglutide / tirzepatide) Budini 2026 ( eClinicalMedicine ) pooled regain curve: asymptotic maximum regain 75.3% of lost weight, half-life about 23 weeks, so roughly 60% of the loss returns by 12 months and about 40% is still held at a year
- says Konstantin Vasyukevich, MD, facial plastic surgeon